Novartis to overhaul Alcon but no 'quick fix': CEO

Swiss pharmaceutical giant Novartis' fourth quarter earnings miss expectations as the group prepares to overhaul its Alcon division.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.